Daniel Rader, University of Pennsylvania, USA, discusses the contrasting effects of apoC3 heterozygous and homozygous loss of function variants on TG levels and coronary artery disease risk, and the potential impact on apoB-containing lipoprotein metabolism.
Please login or create a FREE account to view this content
Educational Supporters of the 11th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:


Guest supporters:



